Catalent common stockholders will obtain $63.50 per share in cash. This reflects a 47.5% premium over the stock's 60-day volume-weighted average price as of 2 February 2024. The company aims to ...

While the $11.7B acquisition price is expected to weigh ... has decided not to begin a share buyback program in 2025. More on Catalent, Novo Nordisk, etc. Novo Nordisk's CagriSema May Trump ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...